These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29081434)

  • 1. Entitled to Addiction?: Pharmaceuticals, Race, and America's First Drug War.
    Herzberg D
    Bull Hist Med; 2017; 91(3):586-623. PubMed ID: 29081434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug abuse control under FDA, 1938-1968.
    Swann JP
    Public Health Rep; 1997; 112(1):83-6. PubMed ID: 9018295
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond a Moment - Reckoning with Our History and Embracing Antiracism in Medicine.
    Paul DW; Knight KR; Campbell A; Aronson L
    N Engl J Med; 2020 Oct; 383(15):1404-1406. PubMed ID: 32722907
    [No Abstract]   [Full Text] [Related]  

  • 4. History and twentieth-century drug policy: telling true stories? Essay review.
    Berridge V
    Med Hist; 2003 Oct; 47(4):518-24. PubMed ID: 14619638
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug legalization and the minority poor.
    Kornblum W
    Milbank Q; 1991; 69(3):415-35. PubMed ID: 1805114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. History of addictions.
    Berridge V; Mars S
    J Epidemiol Community Health; 2004 Sep; 58(9):747-50. PubMed ID: 15310799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adequate controls for new drugs: good manufacturing practice and the 1938 federal Food, Drug, and Cosmetic Act.
    Cooper DE
    Pharm Hist; 2002; 44(1):12-23. PubMed ID: 12068915
    [No Abstract]   [Full Text] [Related]  

  • 8. The liberal state and the rogue agency: FDA's regulation of drugs for mood disorders, 1950s-1970s.
    Shorter E
    Int J Law Psychiatry; 2008; 31(2):126-35. PubMed ID: 18343498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs of abuse.
    Moffat AC
    Sci Justice; 2000; 40(2):89-92. PubMed ID: 10929450
    [No Abstract]   [Full Text] [Related]  

  • 10. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation.
    Daemmrich A
    Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740
    [No Abstract]   [Full Text] [Related]  

  • 11. The Atlanta Falcon and Tono-Bungay: dietary supplements as subprime drugs.
    Weissmann G
    FASEB J; 2009 May; 23(5):1279-82. PubMed ID: 19406845
    [No Abstract]   [Full Text] [Related]  

  • 12. The Federal Food and Drug Administration in the United States: born and bred in crises.
    Taylor WJ
    Int J Clin Pharmacol; 1973 Apr; 7(2):156-62. PubMed ID: 4581340
    [No Abstract]   [Full Text] [Related]  

  • 13. Changing places: illicit drugs, medicines, tobacco and nicotine in the nineteenth and twentieth centuries.
    Berridge V
    Clio Med; 2002; 66():11-34. PubMed ID: 12028669
    [No Abstract]   [Full Text] [Related]  

  • 14. Redesigning Racial Caste in America via Mass Incarceration.
    Graff G
    J Psychohist; 2015; 43(2):120-33. PubMed ID: 26462404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The goose that laid the golden capsule, part I.
    Smith BE
    Tenn Med; 2005 May; 98(5):224-5. PubMed ID: 15934531
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibiotics, big business, and consumers. The context of government investigations into the postwar American drug industry.
    Bud R
    Technol Cult; 2005 Apr; 46(2):329-49. PubMed ID: 16116706
    [No Abstract]   [Full Text] [Related]  

  • 17. The great drug policy debate--what means this thing called decriminalization?
    Bayer R
    Milbank Q; 1991; 69(3):341-63. PubMed ID: 1805112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invisible monuments and the costs of pharmaceutical regulation: twenty-five years of drug lag debate.
    Daemmrich A
    Pharm Hist; 2003; 45(1):3-17. PubMed ID: 12691078
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioequivalence: the regulatory career of a pharmaceutical concept.
    Carpenter D; Tobbell DA
    Bull Hist Med; 2011; 85(1):93-131. PubMed ID: 21551918
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.